Jared Gollob, Chief Medical Officer: Kymera Therapeutics KYMR Sell · Filed 25/10/15

Trade details

Type: Insider sale
Amount: $1,766,667.68
Shares · price: 29,264 sh · $60.37 a share
Held after: 140,304 sh
Stock: Kymera Therapeutics KYMR
Person: Jared GollobChief Medical Officer
Trade date: 25/10/15
Filed: 25/10/15
Days to filing: 0 days

Sold 17.3% of holdings

Share of holding sold: 17.3%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/15~25/11/14

Jared Gollob's recent trades

Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$273.3K
3,048 sh
$273.3K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$214.2K
2,519 sh
$214.2K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$132.5K
1,510 sh
$132.5K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$123.3K
1,437 sh
$123.3K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$93.4K
1,055 sh
$93.4K
Filed 03/04
Traded 03/02

Jared Gollob, Chief Officer — sold $1.8M of Kymera Therapeutics KYMR · 17.3% of holdings · 10b5-1 plan | Whalegun